In the present study, we found that bone-metastatic NSCLC cell-produced IL-8 is functionally required for their osteolytic bone metastasis, and also showed that targeting IL-8 could be a new strategy to interrupt lung cancer bone metastasis. Here, CXCL8 is linked to non-small cell lung carcinoma.